What to know
Stay up to date on news, activities, resources, and reports for partners committed to a future free of HIV, viral hepatitis, STIs, and tuberculosis.
The Latest
![[thumbnail] (hidden)](/nchhstp/media/images/2026/02/2026-MPOX-Web-Thumbnail_2.png)
The overall U.S. STI burden remains substantial, but signs of progress continue.
Lenacapavir as PrEP demonstrates strong efficacy and no serious safety concerns in preventing HIV.
Update on CDC leadership, NCHHSTP labs, Hepatitis C Virus (HCV) module, and NCHHSTP publications
Surveillance reports, AtlasPlus updates, get CDC printed materials, National HIV Testing Day